Amneal Pharmaceuticals (AMRX) Change in Taxes (2020)

Amneal Pharmaceuticals (AMRX) recorded quarterly Change in Taxes of $110.1 million in Q1 2020.

Amneal Pharmaceuticals (AMRX) Change in Taxes (2020) Analysis & Trends

Amneal Pharmaceuticals' Change in Taxes history runs 1 years deep, the most recent figure standing at $110.1 million for Q1 2020.

  • In Q1 2020, Change in Taxes changed N/A year-over-year to $110.1 million; the TTM figure through Jun 2021 stood at $110.1 million (changed 0.0% YoY), while the FY2018 annual figure was $35.0 million, changed N/A from the prior year.
  • Change in Taxes was $110.1 million for Q1 2020 at Amneal Pharmaceuticals.
  • In the past five years, Change in Taxes ranged from a high of $110.1 million in Q1 2020 to a low of $110.1 million in Q1 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Taxes (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 73.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 119.80 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Amneal Pharmaceuticals 4.66 Bn 4.65 Bn 320.11 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2020 110.07 Mn
Mar 31, 2020 110.07 Mn